AI diagnostic opportunity assessment
The challenge
One of our pharma clients was evaluating an investment into several AI and biomarker diagnostic solutions that could improve overall diagnosis rates for a rare disease.
Our solution
We evaluated the client knowledge base of the disease area and patient journey across real-world data (RWD) and primary market insights. Our experts organized these insights within an opportunity assessment framework and identified key knowledge gaps. We also conducted qualitative HCP research to complete the assessment.
The results
We developed strategic recommendations for our client around the opportunity assessment of these AI diagnostic technologies, which enabled the client to push forward with further investment.
Jump to a slide with the slide dots.
How can AI-powered speech analytics scale call monitoring and improve agent performance?
Discover how Inizio Engage used AI-driven speech analytics to scale call monitoring, enhance agent performance, and improve customer interactions.
Read moreHow DataGateway unified oncology data for real-world insights & market intelligence
A global biopharma company used DataGateway platform to unify complex oncology data into a validated, patient-level dataset - boosting coverage by 80%
Read moreHow can AI-powered call routing transform customer experience and drive operational efficiency?
Discover how an AI-powered Virtual Agent streamlined call routing - reducing manual triage by 50% and enhancing customer experience.
Read more